Table 4.

Estimated rates of vaccine-attributable myocarditis/pericarditis cases post second dose of the primary series, by age subgroup, for 1 million fully vaccinated male individuals with Moderna CVmRNA.

Age Group	Moderna CVmRNA Adjusted Rate per 1 M Doses Point Estimate and 95% CI	Data Source (DP = CBER BEST Data Partner)
18–25	127.8 [67.8, 241.2]	DP1-4
26–35	31.8 [8.5, 118.9]	DP1-4
36–45	23.1 [11.3, 47.2]	DP1-4
46–55	12.5 [6.9, 22.8]	DP1-4
56–64	9.6 [3.9, 23.3]	DP1-4